Phase-III clinical trials with Pegylated Interferon Alpha 2b, which company sells under the brand name 'PegiHep' has shown promising results in treati
Siddharth Sedani, Vice President, Equity Advisory, Anand Rathi Shares and Stock Brokers, also says selective midcaps and small-caps may outperform lar